MORF Morphic Holding, Inc.

Morphic Holding, Inc. operates as a biopharmaceutical company, which engages in the research and development of oral small-molecule integrin therapeutics. It operates a Morphic integrin technology platform, MInT platform, to create a broad pipeline of programs across a variety of therapeutic areas. The company was founded by Timothy A. Springer in August 2014 and is headquartered in Waltham, MA.

$58.95  +0.78 (1.34%)
As of 10/26/2021 15:59:20 EST     IEX book   CBOE book


Security Information
Category1:  US Equity
Category2:  Common stocks
Category3:  Mid cap
GICS sector:  Health Care
Industry:  Biotechnology
Index country:  USA
Country of incorporation:  USA
IPO date:  06/27/2019
Outstanding shares:  36,451,080
Average volume:  137,564
Market cap:   $2,117,443,237
Current dividend yield:  0.00%
All SEC filings:     SEC Edgar Online
Quarterly filings:   10-Q
Annual filings:      10-K
CUSIP:    61775R105
ISIN:        US61775R1059
Sedol:      
Valuation   (See tab for details)
PE ratio:   -34.48
PB ratio:   6.07
PS ratio:   54.61
Return on equity:   -17.68%
Net income %:   -158.61%

2021 © Stock Market MBA, Inc. Terms of use | Privacy policy